Logo

Color Genomics

Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access
Premium

The MAGENTA and ProGen trials showed that

Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity

Many companies and counselors see the COVID-19 pandemic as a catalyst for moving germline risk testing into a digital-first healthcare model.

Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction
Premium

The researchers believe their findings could be used to change how patients' risk for breast cancer, colon cancer, or heart disease is calculated.

Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients

Researchers found that 14 percent of individuals with metastatic breast cancer had risky mutations germline mutations, including patients who did not meet testing criteria.

Study Documents Underuse of HBOC Testing in African American Breast Cancer Patients
Premium

Investigators used gene panel testing to assess hereditary breast and ovarian cancer risk in African American women with breast cancer, uncovering potential gaps in test access.